Dr. Reddy's launches India-approved Obeda tablet for type 2 diabetes
NewsBytes | May 20, 2026 9:40 PM CST
Obeda Phase III shows safety, efficacy
Obeda proved just as safe and effective as the original drug in a Phase III trial with 288 people, helping with blood sugar control and weight loss, without triggering anti-drug antibodies.
Prices start at ₹99 for 3 mg, making it a wallet-friendly option for millions living with diabetes in India.
Dr. Reddy's CEO says it is committed to keeping treatment high-quality and within reach for everyone who needs it.
READ NEXT
-
Capricorn Tarot Horoscope Today, May 22, 2026: Self-restraint will prevail, proceed with logic
-
Aquarius Tarot Horoscope Today, May 22, 2026: Stay Consistent and Show Your Creative Side
-
Horoscope Today: Astrological Forecast for May 22, 2026, for All Zodiac Signs
-
Libra Tarot Horoscope Today, May 22, 2026: Stay Proactive and Strengthen Your Management Skills
-
‘CID Tortured Me To Confess’: Man Alleges Wrongful Arrest In Suvendu Aide Murder Probe After Name Mix-Up
